Contraceptive Drugs And Devices Market Forecast Highlights Expansion From $28.9 Billion To $38.08 Billion Through 2030
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Contraceptive Drugs And Devices Market Value Expansion And Long-Term Growth Outlook
The contraceptive drugs and devices market has experienced robust expansion in recent years. It is anticipated to increase from $26.98 billion in 2025 to $28.9 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.1%. This historic upswing has been driven by government-led family planning initiatives, heightened awareness of reproductive health, rising urbanization and education levels, broader accessibility of oral contraceptives, and public health campaigns focused on birth control.
The contraceptive drugs and devices market is projected to experience robust expansion over the next several years, anticipated to reach $38.08 billion by 2030 at a compound annual growth rate of 7.1%. This forecasted growth is driven by several factors, including the increasing integration of digital health solutions, a rising preference for non-invasive contraceptive options, the broader availability of telehealth-based prescriptions, intensified research into male contraception, and the implementation of supportive reproductive health policies. Key developments expected to shape the sector during this period include a higher adoption rate of long-acting reversible contraceptives, the growing use of hormonal combination therapies, a stronger focus on female-centric contraceptive products, the widening accessibility of over-the-counter contraceptive items, and the expanding acceptance of digital platforms for contraception management.
Download A Free Sample Report For Comprehensive Market Insights:
Contraceptive Drugs And Devices Market Expansion Drivers: What Is Shaping Future Growth?
The growing number of government programs focused on reproductive health is anticipated to drive the growth of the contraceptive drugs and devices market in the coming years. These governmental efforts advance reproductive health by providing education, financial support, and improved service access. An increase in such initiatives is observed due to a heightened acknowledgment of the necessity to tackle issues like maternal care, family planning, and the provision of vital health services, all of which are essential for broader societal progress and welfare. Government measures related to contraceptive drugs and devices are designed to enhance the availability of low-cost and effective family planning options, empowering individuals to make well-informed decisions regarding their reproductive health. For example, as reported in November 2024 by the Australian Government Department of Foreign Affairs and Trade, a federal agency in Australia, the country will commit $56.8 million to a new program promoting sexual and reproductive health and rights across Southeast Asia. Consequently, the proliferation of government initiatives on reproductive health is fueling the expansion of the contraceptive drugs and devices market.
Contraceptive Drugs And Devices Market Segment Outlook: Which Categories Are Expanding The Fastest?
The contraceptive drugs and devices market covered in this report is segmented –
1) By Product: Contraceptive Drugs, Contraceptive Devices
2) By Technology: Traditional Methods, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels
4) By End User: Male, Female
Subsegments:
1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants
2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices
Contraceptive Drugs And Devices Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Key players in the contraceptive drugs and devices market are introducing new products like contraceptive vaginal rings to improve ease of use and broaden the range of long-acting contraception. A contraceptive vaginal ring is a flexible device that releases hormones and is placed in the vagina to stop ovulation and prevent pregnancy. An example is EnilloRing, which was launched by Xiromed LLC, a pharmaceutical company based in the US, in October 2023. This soft and flexible contraceptive ring is inserted into the vagina, releasing a steady combination of etonogestrel, a progestin, and ethinyl estradiol, an estrogen, for three weeks to suppress ovulation. As a generic version that is bioequivalent to NuvaRing, it provides women with a convenient, discreet, and affordable monthly birth control solution that removes the need for a daily pill, while offering the same safety, effectiveness, and tolerance as the branded option.
Contraceptive Drugs And Devices Market Key Companies And Competitive Benchmarking
Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.
Access The Complete Contraceptive Drugs And Devices Market Report:
Contraceptive Drugs And Devices Market Largest Region By Revenue And Market Share
North America was the largest region in the contraceptive drugs and devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
